"10.1371_journal.pone.0147319","plos one","2016-01-26T00:00:00Z","Yosef Berlyand; Daniel Weintraub; Sharon X Xie; Ian A Mellis; Jimit Doshi; Jacqueline Rick; Jennifer McBride; Christos Davatzikos; Leslie M Shaw; Howard Hurtig; John Q Trojanowski; Alice S Chen-Plotkin","Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: ACP. Performed the experiments: JD LMS YB. Analyzed the data: IAM SXX YB ACP. Contributed reagents/materials/analysis tools: DW JR JM HH ACP CD JQT. Wrote the paper: YB ACP. Edited the manuscript: YB ACP DW JR JM HH IAM SXX LMS JQT JD CD.","Dr. Trojanowski may accrue revenue in the future on patents submitted by the University of Pennsylvania wherein he is co-Inventor and he received revenue from the sale of Avid to Eli Lilly as co-inventor on imaging related patents submitted by the University of Pennsylvania. He receives research support from the NIH, GSK, Janssen, Biogen and several non-profits. Dr. Chen-Plotkin is the inventor of a patent pending from the University of Pennsylvania on biomarkers for Parkinson’s disease diagnosis; the biomarkers covered by this patent do not concern cognition. Dr. Weintraub has received research funding or support from Michael J. Fox Foundation for Parkinson’s Research, NIH, Novartis Pharmaceuticals, Department of Veterans Affairs, and Avid Radiopharmaceuticals; honoraria from AbbVie, Biotie, Teva Pharmaceuticals, Otsuka, UCB, Clintrex LLC, and the CHDI Foundation; license fee payments from UPenn for the QUIP and QUIP-RS; royalties from Wolters Kluweland; and fees for legal consultation for lawsuit related to antipsychotic prescribing in a PD patient.",NA,NA,NA,"2016","01","Yosef Berlyand","YB",12,TRUE,1,3,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
